Coronary Heart Disease Diagnostic Imaging Devices Market By Type of Device (X-ray Imaging Systems, CT Scanners, MRI Systems, Ultrasound Imaging Systems), By End-User (Hospitals, Diagnostic Centers, Cardiology Clinics, Research Institutes), By Technology (Digital Imaging, Analog Imaging, 3D Imaging, Hybrid Imaging), By Application (Diagnosis of Coronary Artery Disease, Coronary Angiography, Myocardial Perfusion Imaging, Stress Testing and Imaging), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Coronary Heart Disease Diagnostic Imaging Devices Market was valued at USD 2.3 Billion in 2024-e and will surpass USD 5.7 Billion by 2030; growing at a CAGR of 13.7% during 2025-2030.

The coronary heart disease (CHD) diagnostic imaging devices market is witnessing rapid growth due to the increasing prevalence of cardiovascular diseases worldwide and the advancements in imaging technologies. The market is crucial for diagnosing coronary artery disease (CAD), enabling early intervention, and improving patient outcomes. Diagnostic imaging devices such as X-ray, CT scanners, MRIs, and ultrasound systems are commonly used to detect coronary heart disease. The demand for these devices is expected to continue growing as the healthcare industry becomes more reliant on non-invasive, accurate, and real-time diagnostic tools. With healthcare providers constantly seeking better ways to manage CHD, the global market is evolving to accommodate a wide range of applications, from diagnosis to treatment monitoring.

X-ray Imaging Systems are Largest Owing to Wide Adoption

X-ray imaging systems are the largest subsegment in the coronary heart disease diagnostic imaging devices market. These devices have long been the standard for detecting and diagnosing a wide variety of cardiovascular conditions, including coronary artery disease. X-ray imaging provides clear and detailed visualizations of the heart and arteries, which are essential for diagnosing blockages or abnormal heart conditions. The portability, speed, and affordability of X-ray machines make them a popular choice in hospitals, diagnostic centers, and cardiology clinics. Additionally, the availability of advanced features such as digital radiography (DR) enhances the diagnostic capabilities, allowing for faster and more accurate results.

The ability to integrate with other diagnostic tools, such as fluoroscopy, makes X-ray imaging systems versatile, driving their dominance in coronary heart disease diagnosis. Moreover, the rise of hybrid imaging technologies, which combine X-ray with other imaging modalities like CT or MRI, has further bolstered the market for X-ray systems. This synergy allows healthcare providers to capture multiple perspectives of the heart, offering a comprehensive view of the condition and enabling more effective treatment planning.

Hospitals Lead as the Largest End-User of Diagnostic Imaging Devices

Hospitals represent the largest end-user segment for coronary heart disease diagnostic imaging devices. With a high volume of patients requiring cardiovascular assessments, hospitals are the primary settings for the adoption of advanced imaging technologies. These institutions have the infrastructure and resources to support the installation and operation of expensive and complex diagnostic imaging equipment such as CT scanners, MRIs, and X-ray systems. The availability of specialized cardiology departments within hospitals allows for a more focused and comprehensive approach to diagnosing and managing coronary artery disease.

Hospitals also benefit from advancements in imaging technology, such as 3D imaging and hybrid imaging systems, which improve diagnostic accuracy and provide detailed insights into the heart's structure and function. With an increasing emphasis on early detection and personalized treatment plans, hospitals are continuously upgrading their diagnostic capabilities to meet the growing demand for coronary heart disease management.

Digital Imaging Technology is Fastest Growing Due to Enhanced Accuracy

Digital imaging technology is the fastest-growing segment within the coronary heart disease diagnostic imaging devices market. As healthcare providers increasingly seek faster, more accurate diagnostic tools, digital imaging has emerged as the preferred technology. Digital radiography offers superior image quality compared to traditional analog systems, and it reduces the need for film development, making it more time-efficient and cost-effective. Additionally, digital systems allow for easier image storage, sharing, and analysis, facilitating remote consultations and improving collaboration among medical professionals.

The use of digital imaging technology also enhances diagnostic accuracy by providing higher resolution images that make it easier to identify early-stage coronary artery disease or other cardiovascular abnormalities. As a result, digital imaging is expected to continue gaining traction across hospitals, diagnostic centers, and cardiology clinics, further accelerating its growth within the coronary heart disease diagnostic imaging market.

Diagnosis of Coronary Artery Disease is Key Application Due to High Demand

The diagnosis of coronary artery disease (CAD) is the most significant application for diagnostic imaging devices in the coronary heart disease market. CAD is one of the leading causes of heart attacks and other cardiovascular complications worldwide, and early detection is critical for improving patient outcomes. Imaging technologies such as X-ray, CT, MRI, and ultrasound play an essential role in diagnosing CAD by providing detailed images of the coronary arteries, enabling healthcare providers to detect blockages or abnormalities.

Given the global rise in lifestyle-related diseases, such as hypertension, diabetes, and obesity, the demand for coronary artery disease diagnostics is expected to grow rapidly. Furthermore, advancements in imaging technologies that allow for non-invasive and accurate assessments are contributing to an increase in the number of patients seeking diagnosis and treatment. The ability to detect CAD at an early stage helps prevent severe health events and enables better management of cardiovascular health.

North America Dominates the Coronary Heart Disease Diagnostic Imaging Market

North America is the largest region in the coronary heart disease diagnostic imaging devices market, driven by the advanced healthcare infrastructure, high adoption rates of cutting-edge technologies, and the rising prevalence of cardiovascular diseases. The U.S., in particular, is a significant contributor to this dominance, with healthcare providers increasingly investing in state-of-the-art imaging equipment to meet the demands of a large and aging population. Moreover, the region benefits from a well-established reimbursement framework that supports the adoption of expensive diagnostic imaging devices.

Technological innovations and the presence of leading diagnostic equipment manufacturers in North America further solidify the region's position in the global market. As healthcare providers focus on improving cardiovascular care through early detection and advanced imaging solutions, North America is expected to maintain its leadership in the coronary heart disease diagnostic imaging devices market in the foreseeable future.

Competitive Landscape and Leading Companies

The competitive landscape of the coronary heart disease diagnostic imaging devices market is highly dynamic, with several leading companies continuously innovating to meet the growing demand for advanced diagnostic tools. Major players such as Siemens Healthineers, GE Healthcare, and Philips Healthcare dominate the market, offering a wide range of imaging systems that cater to various diagnostic needs. These companies invest heavily in research and development to enhance the functionality of their imaging devices, integrating features such as digital imaging, 3D imaging, and hybrid imaging technologies to improve diagnostic accuracy.

In addition to technological advancements, partnerships and acquisitions play a significant role in strengthening market positions. For example, collaborations between imaging device manufacturers and healthcare providers are helping to improve product accessibility and service delivery. With increasing competition and a constant focus on innovation, the coronary heart disease diagnostic imaging devices market is poised for continued growth and development in the coming years.

List of Leading Companies:

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems
• Hitachi Medical Corporation
• Samsung Medison
• Mindray
• Shimadzu Corporation
• Fujifilm Holdings Corporation
• Toshiba Medical Systems
• Hologic, Inc.
• Esaote S.p.A.
• Medtronic
• Nipro Corporation
• Carestream Health, Inc.

Recent Developments:

• Siemens Healthineers launched a new advanced CT scanner designed for coronary imaging, providing higher resolution images and reduced radiation exposure for better diagnosis.
• GE Healthcare received FDA approval for its latest cardiac MRI system, which integrates artificial intelligence for faster and more accurate coronary disease detection.
• Philips Healthcare partnered with Medtronic to integrate coronary diagnostic imaging with their heart failure management solutions, enhancing diagnostic accuracy.
• Canon Medical Systems unveiled a new ultrasound imaging device optimized for coronary artery disease, offering better image quality and faster results in clinical settings.
• Mindray announced the acquisition of Diagnostic Ultrasound Corporation to expand its range of cardiac imaging devices and improve its presence in the coronary heart disease diagnostics market.

Report Scope: